Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Toggle navigation
Contact Us
Subscribe
Promote Your Event
e-Edition
Privacy Policy
Terms of Service
Local Weather
Home Delivery
Submission Forms
News
Local News
The Leader
Heartland News
Sports
Entertainment
Local Events
Multimedia
Photo Galleries
Videos
Obituaries
Classifieds
Real Estate
Property for Rent
Cars & Vehicles
Jobs
Items for Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place an ad
Legals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atyr Pharma Inc
(NQ:
LIFE
)
2.470
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.470
Bid (Size)
2.200 (2)
Ask (Size)
3.000 (2)
Prev. Close
2.470
Today's Range
2.470 - 2.470
52wk Range
2.000 - 6.620
Shares Outstanding
29,009,382
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
12 Health Care Stocks Moving In Friday's After-Market Session
February 03, 2023
Via
Benzinga
This Company Is Beginning A Pivotal Phase 3 EFZO-FIT™ Study. Could It Be A Much-Needed Treatment For Pulmonary Sarcoidosis?
November 29, 2022
Most people may never have heard of sarcoidosis, an inflammatory disease that affects about 1.2 million people worldwide.
Via
Benzinga
Performance
YTD
+4.66%
+4.66%
1 Month
+2.92%
+2.92%
3 Month
+3.78%
+3.78%
6 Month
-32.88%
-32.88%
1 Year
-55.58%
-55.58%
More News
Read More
Stocks That Hit 52-Week Lows On Friday
November 18, 2022
Via
Benzinga
aTyr Pharma: Q2 Earnings Insights
August 15, 2022
Via
Benzinga
Beat Of Life Entertainment- A One Stop Solution For Internet Marketing
October 08, 2022
Via
IssueWire
Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary
September 13, 2022
Via
Benzinga
aTyr Pharma Gets FDA Fast Track Status For Systemic Sclerosis Candidate
September 13, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 13, 2022
Via
Benzinga
NexImmune Price Target Cut By 75%, Plus Wells Fargo Lowers PT Price Target On These Stocks
August 16, 2022
Via
Benzinga
Earnings Scheduled For August 15, 2022
August 15, 2022
Via
Benzinga
A Preview Of aTyr Pharma's Earnings
August 12, 2022
Via
Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 11, 2022
Via
Benzinga
aTyr Pharma Shares Ascend As FDA Grants Fast Track Status To Lung Disease Candidate
August 11, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 11, 2022
Via
Benzinga
Snap to $25? Plus This Analyst Cuts Price Target On Amazon.com
July 21, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 13, 2022
Via
Benzinga
$1.4 Million Bet On This Healthcare Stock? 4 Penny Stocks Insiders are Buying
July 07, 2022
Via
Benzinga
The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More
May 16, 2022
Via
Benzinga
Earnings Outlook For aTyr Pharma
May 06, 2022
Via
Benzinga
Earnings Scheduled For May 9, 2022
May 09, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
April 14, 2022
Via
Benzinga
58 Biggest Movers From Yesterday
March 24, 2022
Via
Benzinga
38 Stocks Moving In Wednesday's Mid-Day Session
March 23, 2022
Via
Benzinga
A Preview Of aTyr Pharma's Earnings
March 11, 2022
Via
Benzinga
Earnings Scheduled For March 14, 2022
March 14, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
